Congressional leaders urge HHS and FDA to act to preserve patient access to insulin detemir (Levemir), a clinically distinct insulin relied upon by pregnant women, children, athletes, and others with specialized needs. For many patients, detemir’s unique pharmacologic profile makes it medically necessary, providing dosing flexibility and safety that are not clinically interchangeable with other long-acting insulins.
Why Insulin Choice Matters: The Fight to Save Levemir
In this powerful episode of Diabetes Connections, Dr. Florence Brown, MD from Harvard Medical School and Joslin Diabetes Center, and Dr. Amy Valent, DO from Oregon Health & Science University, explain why Levemir is uniquely essential.
Unlike longer-acting insulins like Lantus or Tresiba, Levemir’s 12-hour duration gives doctors the flexibility to quickly adjust doses — especially critical during pregnancy when insulin needs change dramatically. The doctors confirm it reduces hypoglycemia risk and allows precise control for pregnant patients, children, and athletes when other options fall short.
Who we are
We are parents, individuals, care providers, and loved ones of those with insulin-dependent diabetes. We are volunteering our time to protect insulin options to ensure patients have access to the life-saving medication that best serves them.
Our goals
Patients harmed by Levemir discontinuation in the Chicago Policy Review.
Update
We believe everyone who uses insulin as a life saving therapy should have access to the insulin of their choice - the insulin that serves them best. Learn more about our current campaign.
Protecting Insulin Choice: Alison Smart’s Fight for Levemir and Those Who Depend on It
Hear the campaign members sharing their concerns in this video.
Shocking news for Type 1 Diabetics: Insulin discontinued
Levemir Discontinuation Crisis: Alison Smart Fights for Insulin Choice 160
What is the Future of Levemir Insulin? EP12 -Fountain of Vitality
Advocating for Type 1 Diabetes Care with Alison Smart on Boundless Body Radio!
Our partners
Join our support base!
Stay up-to-date with our advocacy news
APIC
Copyright Notice
All Rights Reserved.
All materials appearing on the Alliancetoprotectinsulinchoice.org website (“content”) are protected by copyright under US Copyright laws and are the property of Alliancetoprotectinsulinchoice.org website owners or the party credited as the provider of the content. You may not copy, reproduce, distribute, publish, display, perform, modify, create derivative works, transmit, or in any way exploit any such content, nor may you distribute any part of this content over any network, including a local area network, sell or offer it for sale, or use such content to construct any kind of database. You may not alter or remove any copyright or other notice from copies of the content on the Alliancetoprotectinsulinchoice.org website. Copying or storing any content except as provided above is expressly prohibited without prior written permission of Alliancetoprotectinsulinchoice.org or the copyright holder identified in the individual content’s copyright notice. For permission to use the content on the Alliancetoprotectinsulinchoice.org website, please contact info@alliancetoprotectinsulinchoice.org